Genus (LON:GNS – Free Report) had its price target hoisted by Deutsche Bank Aktiengesellschaft from GBX 2,550 to GBX 2,900 in a report issued on Monday, Marketbeat reports. They currently have a buy rating on the stock.
Separately, Shore Capital restated a “buy” rating and set a GBX 2,900 price target on shares of Genus in a research note on Thursday, September 4th. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Genus has a consensus rating of “Buy” and an average price target of GBX 2,900.
Read Our Latest Research Report on Genus
Genus Trading Down 3.8%
Genus (LON:GNS – Get Free Report) last posted its quarterly earnings results on Thursday, September 4th. The company reported GBX 81.80 EPS for the quarter. Genus had a net margin of 1.18% and a return on equity of 1.41%. Sell-side analysts expect that Genus will post 70.9644323 earnings per share for the current year.
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
See Also
- Five stocks we like better than Genus
- Find and Profitably Trade Stocks at 52-Week Lows
- Reddit Hits Record Highs: Why Wall Street Is Taking Notice
- Bank Stocks – Best Bank Stocks to Invest In
- After a Strong Wall Street Debut, Klarna’s Real Work Begins
- What Are Dividend Achievers? An Introduction
- 3 Dividend Growers That Fly Under the Radar
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.